Fairway Consulting Group Recognized as a Top 40 Life Sciences Executive Search Firm by Hunt Scanlon
29 juil. 2024 13h02 HE
|
Fairway Consulting Group
Fairway Consulting Group (FCG) named as a Top 40 Life Sciences Executive Search Firm by Hunt Scanlon Media.
Global Metabolomics Technologies and Markets, 2021-2023 & 2024-2029: Lucrative Opportunities in Precision Medicine and Personalized Healthcare, Drug Discovery, & Biomarker Discovery and Validation
29 juil. 2024 07h18 HE
|
Research and Markets
Dublin, July 29, 2024 (GLOBE NEWSWIRE) -- The "Metabolomics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for metabolomics...
Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial Results
29 juil. 2024 07h02 HE
|
Ocugen
MALVERN, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
eLabNext and ABI-LAB Announce Strategic Partnership to Foster Innovation in Life Sciences
26 juil. 2024 11h59 HE
|
eLabNext; ABI-LAB
eLabNext and ABI-LAB have announced a strategic alliance aimed at driving innovation and supporting the growth of life sciences startups.
Cytokinetics to Announce Second Quarter Results on August 8, 2024
25 juil. 2024 16h00 HE
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 8, 2024 at...
[Latest] US Biotechnology Market Size/Share Worth USD 1797.8 Billion by 2033 at a 12.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
25 juil. 2024 13h30 HE
|
Custom Market Insights
Austin, TX, USA, July 25, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Biotechnology Market Size, Trends and Insights By Technology...
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
25 juil. 2024 08h30 HE
|
FN Media Group LLC
PALM BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The fibromyalgia treatment market has witnessed positive growth trends over the past few years. There is higher...
Ocugen, Inc. Announces Completion of Dosing in Subjects with Geographic Atrophy Secondary to dAMD in High-Dose Cohort of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Novel Modifier Gene Therapy
25 juil. 2024 06h30 HE
|
Ocugen
• Initiated Phase 2 clinical trial MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused on discovering,...
TransCode Therapeutics, Inc. Announces Closing of Public Offering
24 juil. 2024 16h05 HE
|
TransCode Therapeutics, Inc.
Boston, MA — July 24, 2024 — TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (“TransCode” or the “Company”), a clinical-stage RNA oncology company committed to
NeOnc Initiates Cohort 3 in Phase 1 Clinical Trial of NEO212™, a Patented Novel Hybrid Drug Designed to Deliver ‘Double Punch’ Against Malignant Brain Tumors
24 juil. 2024 11h15 HE
|
NeOnc Technologies Holdings, Inc.
NEO212™ completes initial two cohorts of Phase 1 study under FDA Investigative New Drug (IND).Study tests the safety of NeOnc’s patented novel drug, NEO212™, which is the bioconjugation of its leading...